These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6458776)

  • 1. Adult GM2 gangliosidosis in association with Tay-Sachs disease: a new phenotype.
    Navon R; Argov Z; Brand N; Sandbank U
    Neurology; 1981 Nov; 31(11):1397-1401. PubMed ID: 6458776
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of hexosaminidase A variant alleles among Ashkenazi Jews and prenatal diagnosis of GM2 gangliosidosis.
    Navon R; Adam A
    Am J Hum Genet; 1985 Sep; 37(5):1031-3. PubMed ID: 2931975
    [No Abstract]   [Full Text] [Related]  

  • 3. GM2 gangliosidosis with a motor neuron disease phenotype: clinical heterogeneity of hexosaminidase deficiency disease.
    Federico A
    Adv Exp Med Biol; 1987; 209():19-23. PubMed ID: 2953177
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases.
    Willner JP; Grabowski GA; Gordon RE; Bender AN; Desnick RJ
    Neurology; 1981 Jul; 31(7):787-98. PubMed ID: 6454083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-onset GM2 gangliosidosis diagnosed in a fetus.
    Navon R; Sandbank U; Frisch A; Baram D; Adam A
    Prenat Diagn; 1986; 6(3):169-76. PubMed ID: 2941730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency.
    Argov Z; Navon R
    Ann Neurol; 1984 Jul; 16(1):14-20. PubMed ID: 6235771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipidoses.
    Sandhoff K
    J Clin Pathol Suppl (R Coll Pathol); 1974; 8():94-105. PubMed ID: 4157247
    [No Abstract]   [Full Text] [Related]  

  • 8. Dystonia in GM2 gangliosidosis.
    Hardie RJ; Morgan-Hughes JA
    Mov Disord; 1992 Oct; 7(4):390-1. PubMed ID: 1484544
    [No Abstract]   [Full Text] [Related]  

  • 9. [GM2 gangliosidosis--Tay-Sacks disease and Sandhoff's disease].
    Okada S
    Nihon Rinsho; 1978 May; Suppl():1394-5. PubMed ID: 691367
    [No Abstract]   [Full Text] [Related]  

  • 10. B1 variant of GM2 gangliosidosis in a 12-year-old patient.
    Goebel HH; Stolte G; Kustermann-Kuhn B; Harzer K
    Pediatr Res; 1989 Jan; 25(1):89-93. PubMed ID: 2521932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tay-Sachs disease in an Arab child.
    Nutman J; Navon R; Nitzan M; Gadoth N
    Isr J Med Sci; 1985 Jan; 21(1):77-8. PubMed ID: 3156104
    [No Abstract]   [Full Text] [Related]  

  • 12. Ultrastructural pathology of skin biopsy and fibroblast enzyme studies in a case of GM2-gangliosidosis with deficient hexosaminidase A and thermolabile hexosaminidase B.
    Burck U; Harzer K; Goebel HH; Elze KL; Held KR; Carstens L
    Neuropadiatrie; 1980 May; 11(2):161-75. PubMed ID: 6255371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
    Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
    Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of keratan sulfate by beta-N-acetylhexosaminidases in GM2-gangliosidosis.
    Yutaka T; Okada S; Kato T; Yabuuhi H
    Clin Genet; 1982 Mar; 21(3):196-202. PubMed ID: 6212169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The juvenile and chronic forms of GM2 gangliosidosis: clinical and enzymatic heterogeneity.
    Specola N; Vanier MT; Goutières F; Mikol J; Aicardi J
    Neurology; 1990 Jan; 40(1):145-50. PubMed ID: 2136940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-onset hexosaminidase A and hexosaminidase A and B deficiency: family study and review.
    Adams C; Green S
    Dev Med Child Neurol; 1986 Apr; 28(2):236-43. PubMed ID: 2940136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
    Charrow J; Inui K; Wenger DA
    Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Picture of the month. Tay-Sachs disease.
    Arisoy AE; Ozden S; Arisoy ES; Kocabay K; Guvenc H; Tunnessen WW
    Am J Dis Child; 1992 Jun; 146(6):767-8. PubMed ID: 1534438
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromatofocusing coupled with automated assay for beta-hexosaminidase isoenzymes in GM2 gangliosidosis.
    Orlacchio A; Maffei C; Emiliani C; Coppa GV; Felici L
    Experientia; 1985 Apr; 41(4):525-7. PubMed ID: 3157597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Tay-Sachs disease by estimation of beta-N-acetylhexosaminidase activity using a radiolabeled hyaluronic acid-derived trisaccharide substrate.
    Yutaka T; Kato T; Midorikawa M; Doke M; Okada S; Yabuuchi H
    Clin Chim Acta; 1984 Feb; 137(2):159-68. PubMed ID: 6231138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.